Ana M Aransay Selected Research

Disease Progression

10/2023

Mitochondrial dysfunction promotes microbial composition that negatively impacts on ulcerative colitis development and progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana M Aransay Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 04/2008
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2015
5	Fibrosis (Cirrhosis) 01/2022 - 04/2008
4	Fatty Liver 01/2023 - 04/2008
4	Inflammation (Inflammations) 01/2022 - 01/2018
3	Non-alcoholic Fatty Liver Disease 11/2017 - 02/2013
3	Ankylosing Spondylitis 06/2013 - 11/2011
2	Liver Neoplasms (Liver Cancer) 03/2024 - 04/2008
2	Carcinogenesis 01/2023 - 07/2015
2	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 04/2008
1	Crohn Disease (Crohn's Disease) 10/2023
1	Hypoxia (Hypoxemia) 10/2023
1	Ulcerative Colitis 10/2023
1	Colitis 10/2023
1	Disease Progression 10/2023
1	Melanoma (Melanoma, Malignant) 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Neurofibrosarcoma (MPNST) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Cholangiocarcinoma 01/2020
1	Glioma (Gliomas) 12/2019
1	Fibromyalgia (Fibrositis) 08/2019
1	7 Hereditary Prostate Cancer 01/2018
1	Cholestasis 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Thymoma (Thymic Carcinoma) 07/2015
1	Premature Aging 04/2014
1	Infections 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2014
4	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2017
3	EnzymesIBA 01/2022 - 04/2008
3	Messenger RNA (mRNA)IBA 01/2020 - 04/2008
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2024 - 01/2020
2	AntigensIBA 03/2024 - 05/2012
2	MethyltransferasesIBA 01/2024 - 12/2019
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2023 - 01/2022
2	Transfer RNA (tRNA)IBA 10/2023 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	ProteomeIBA 12/2019 - 11/2017
2	CytokinesIBA 08/2019 - 04/2008
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2018
2	PolyaminesIBA 01/2018 - 01/2017
2	Methionine (L-Methionine)FDA Link 11/2017 - 04/2008
2	S-Adenosylmethionine (Ademetionine)IBA 01/2017 - 09/2012
2	prelamin AIBA 04/2014 - 04/2012
2	HLA-DPA1 antigen (HLA DPA1)IBA 06/2013 - 11/2011
2	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 09/2012 - 04/2008
1	Long Noncoding RNAIBA 10/2023
1	AngiomotinsIBA 10/2023
1	AsparagineIBA 10/2023
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2023
1	Immunoglobulin A (IgA)IBA 10/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	InflammasomesIBA 02/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Tricarboxylic AcidsIBA 01/2022
1	CateninsIBA 01/2020
1	Cytostatic AgentsIBA 01/2020
1	5-Methylcytosine (5 Methylcytosine)IBA 12/2019
1	Glutamic Acid (Glutamate)FDA Link 08/2019
1	Microphthalmia-Associated Transcription FactorIBA 10/2018
1	Crystallins (Crystallin)IBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Simvastatin (Zocor)FDA LinkGeneric 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	LigandsIBA 01/2018
1	Trefoil FactorsIBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Choline (Choline Chloride)IBA 11/2017
1	aramcholIBA 11/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	S-adenosyl-3-methylthiopropylamineIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Methionine AdenosyltransferaseIBA 01/2017
1	Cadherins (E-Cadherin)IBA 02/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2015
1	TOR Serine-Threonine KinasesIBA 07/2015
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2013
1	AntioxidantsIBA 02/2013
1	LipidsIBA 02/2013
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2013
1	Phosphotransferases (Kinase)IBA 09/2012
1	Peptides (Polypeptides)IBA 09/2012
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 09/2012
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2012
1	Adenosine (Adenocard)FDA LinkGeneric 09/2012

Therapy/Procedure

4	Therapeutics 10/2023 - 04/2012
1	Biological Therapy 10/2023
1	Fecal Microbiota Transplantation 10/2023
1	Drug Therapy (Chemotherapy) 10/2023
1	Immunotherapy 01/2023
1	Ligation 01/2018